Abstract:As scientific understandings of genetics advance, researchers require increasingly rich datasets that combine genomic data from large numbers of individuals with medical and other personal information. Linking individuals' genetic data and personal information precludes anonymity and produces medically significant information--a result not contemplated by the established legal and ethical conventions governing human genomic research. To pursue the next generation of human genomic research and commerce in a responsible fashion, scientists, lawyers, and regulators must address substantial new issues, including researchers' duties with respect to clinically significant data, the challenges to privacy presented by genomic data, the boundary between genomic research and commerce, and the practice of medicine. This Article presents a new model for understanding and addressing these new challenges--a "public genomics" premised on the idea that ethically, legally, and socially responsible genomics research requires openness, not privacy, as its organizing principle. Responsible public genomics combines the data contributed by informed and fully consenting information altruists and the research potential of rich datasets in a genomic commons that is freely and globally available. This Article examines the risks and benefits of this public genomics model in the context of an ambitious genetic research project currently under way--the Personal Genome Project. This Article also (i) demonstrates that large-scale genomic projects are desirable, (ii) evaluates the risks and challenges presented by public genomics research, and (iii) determines that the current legal and regulatory regimes restrict beneficial and responsible scientific inquiry while failing to adequately protect participants. The Article concludes by proposing a modified normative and legal framework that embraces and enables a future of responsible public genomics.

Key Expert Stakeholder Perceptions of the Law of Genomics: Identified Problems and Potential Solutions

Enabling responsible public genomics

The law of genetic privacy: applications, implications, and limitations

Future-proofing genomic data and consent management: a comprehensive review of technology innovations

From Genetics to Genomics: Facing the Liability Implications in Clinical Care

Trends in ethical and legal frameworks for the use of human biobanks

Managing expectations, rights, and duties in large-scale genomics initiatives: a European comparison

Exploring the potential duty of care in clinical genomics under UK law

Privacy in the Genomic Era

How Can Law and Policy Advance Quality in Genomic Analysis and Interpretation for Clinical Care?

Economic regulation of next-generation sequencing

The public-private research ecosystem in the genome editing era

Towards a trusted genomics repository: Identifying commercialisation fears and preferred forms of governance across segments of the community

Legal aspects of privacy-enhancing technologies in genome-wide association studies and their impact on performance and feasibility

Community-led risk analysis of direct-to-consumer whole-genome sequencing

Tensions in ethics and policy created by National Precision Medicine Programs

Privacy and ethical challenges in next-generation sequencing

Genetic Research: The Role of Citizens, Public Health and International Stakeholders

Machine learning and genomics: precision medicine vs. patient privacy

Confidentiality, privacy, and security of genetic and genomic test information in electronic health records: points to consider

General-Purpose Privacy Regulation and Translational Genomics